For decades, the movement toward value-based reimbursement (VBR) models in the United States has been “glacial”—slow but sure, changing everything in its path. But the pandemic has accelerated the movement to value. And, the movement has been fueled by recent developments—tightened government budgets in a recovering economy, a focus on “whole person” approaches to care management, the entry of digital and investor-backed competitors into the specialty health care space, and health plans trending toward backward integration in a bid to own provider organization capacity. Even though many health plans are struggling to operationalize VBR arrangements and . . .